|Day Low/High||0.08 / 0.08|
|52 Wk Low/High||0.03 / 0.14|
Including University Status and Drug Development Programs Currently Underway
The woes of anti-marijuana Attorney General Jeff Sessions are fueling speculative pot stock buying. But you should avoid these two high flying small fry.
GW Pharmaceuticals saw its stock price surge amid news of a successful Epidiolex clinical trial. But that high also generated buzz across pot stocks at large.
Openfolio surveyed the portfolios of its pool of over 20,000 investors to see the effect penny stocks have on overall performance.
Researchers complain the pot the government now supplies is of poor quality. The government contract is open for bidding, but growers say the hurdles are insurmountable.
Penny stock publisher Peter Leeds finds most pot companies to be very high risk and cautions investors to wait until prices drop.
Investing in hot growth stocks at high prices often ends badly.
Cannabis Science Inc (NASD OTC: CBIS) and the World AIDS Institute announced today the appointment of Robert Melamede, PhD, Professor of Biology at the University of Colorado, Colorado Springs and CEO of Cannabis...
Cannabis Science (NASD OTC: CBIS), a pioneering U.S.
Cannabis Science Inc., (CBIS) announced today the appointment of Ronald Sekura PH.
Cannabis Science (CBIS) announced today the appointment of J. Thomas August, MD, Professor, Pharmacology and Molecular Sciences, and Oncology, The Johns Hopkins School of Medicine, to the Company’s Scientific...
Cannabis Science ( CBIS), a pioneering U.S.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.